| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108 | KING | USA | Drug Abuse and Addiction Research Programs | 000 | 3 | 2/8/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $383,910 ) |
| 2023 | 2023 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108 | KING | USA | Drug Abuse and Addiction Research Programs | 000 | 3 | 7/17/2023 | NON-COMPETING CONTINUATION | $383,910 |
|
| Issue Date FY: 2022 ( Subtotal = $408,546 ) |
| 2022 | 2022 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY # 151F | SEATTLE | WA | 98108 | KING | USA | Drug Abuse and Addiction Research Programs | 000 | 2 | 6/27/2022 | NON-COMPETING CONTINUATION | $408,546 |
|
| Issue Date FY: 2021 ( Subtotal = $337,192 ) |
| 2021 | 2021 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY # 151F | SEATTLE | WA | 98108 | KING | USA | Drug Abuse and Addiction Research Programs | 000 | 1 | 7/29/2021 | NEW | $337,192 |
|
|